ATE332894T1 - Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe - Google Patents

Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe

Info

Publication number
ATE332894T1
ATE332894T1 AT01928133T AT01928133T ATE332894T1 AT E332894 T1 ATE332894 T1 AT E332894T1 AT 01928133 T AT01928133 T AT 01928133T AT 01928133 T AT01928133 T AT 01928133T AT E332894 T1 ATE332894 T1 AT E332894T1
Authority
AT
Austria
Prior art keywords
pyridine
implementation
active ingredients
oxide
pharmaceutical active
Prior art date
Application number
AT01928133T
Other languages
English (en)
Inventor
Laszlo Ueroegdi
Csakai Zita Jegesne
Lajos Gruber
Laszlo Oetvoes
Juzsef Toth
Istvan Toemoeskoezi
Schmidt Aniku Szakacsne
Ferencne Reider
Barlay Maria Schneiderne
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Application granted granted Critical
Publication of ATE332894T1 publication Critical patent/ATE332894T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01928133T 2000-04-18 2001-04-17 Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe ATE332894T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0001583A HUP0001583A2 (hu) 2000-04-18 2000-04-18 Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké

Publications (1)

Publication Number Publication Date
ATE332894T1 true ATE332894T1 (de) 2006-08-15

Family

ID=90001563

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01928133T ATE332894T1 (de) 2000-04-18 2001-04-17 Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe

Country Status (31)

Country Link
US (1) US7126002B2 (de)
EP (1) EP1274685B1 (de)
JP (1) JP5066638B2 (de)
KR (1) KR100742482B1 (de)
CN (1) CN1216868C (de)
AT (1) ATE332894T1 (de)
AU (2) AU2001254997B2 (de)
BG (1) BG65889B1 (de)
BR (1) BRPI0110184B8 (de)
CA (1) CA2406266C (de)
CY (1) CY1107473T1 (de)
CZ (1) CZ301576B6 (de)
DE (1) DE60121431T2 (de)
DK (1) DK1274685T3 (de)
EE (1) EE05085B1 (de)
ES (1) ES2267758T3 (de)
HR (1) HRP20020825A2 (de)
HU (1) HUP0001583A2 (de)
IL (2) IL152337A0 (de)
MX (1) MXPA02010320A (de)
NO (1) NO323535B1 (de)
NZ (1) NZ522017A (de)
PL (1) PL359826A1 (de)
PT (1) PT1274685E (de)
RS (1) RS51003B (de)
RU (1) RU2281282C2 (de)
SI (1) SI1274685T1 (de)
SK (1) SK287606B6 (de)
UA (1) UA75353C2 (de)
WO (1) WO2001079174A1 (de)
ZA (1) ZA200208460B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
HU0103939D0 (en) * 2001-09-27 2001-11-28 Biorex Kutato Fejlesztoe Kft Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
CA2471752A1 (en) * 2002-01-11 2003-07-17 Biorex Kutato Es Fejlesztoe Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
TW200831479A (en) * 2006-09-26 2008-08-01 Cytrx Corp Pharmaceutical compositions and methods for treating diseases
EP2484371B1 (de) 2008-06-26 2014-12-17 Orphazyme APS Verwendung von HSP70 als Regler der enzymatischen Aktivität
RU2013125923A (ru) 2010-11-30 2015-01-10 Орфазиме Апс СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
US10709700B2 (en) 2014-09-15 2020-07-14 Orphazyme A/S Arimoclomol formulation
EP3442530A1 (de) 2016-04-13 2019-02-20 Orphazyme A/S Hitzeschockproteinen und cholesterinhomöostase
SI3448382T1 (sl) 2016-04-29 2021-03-31 Orphazyme A/S, c/o COBIS A/S Arimoclomol za zdravljenje motenj, povezanih z glukocerebrozidazo
AU2018337761C1 (en) 2017-09-22 2025-01-30 Adelaide university Methods and products for improving sperm quality
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
WO2021260120A1 (en) 2020-06-24 2021-12-30 Orphazyme A/S Arimoclomol for treating gaucher disease
CN116783164A (zh) * 2020-11-19 2023-09-19 泽维拉丹麦股份有限公司 制备柠檬酸阿瑞洛莫及其中间体的方法
WO2022106614A1 (en) 2020-11-19 2022-05-27 Orphazyme A/S Processes for preparing arimoclomol citrate and intermediates thereof
JP2024502304A (ja) 2020-12-24 2024-01-18 ゼブラ デンマーク エー／エス Ｅｒ型ミスセンス変異を有する患者におけるニーマンピック病ｃ型の治療用アリモクロモル
WO2025014519A1 (en) 2023-07-10 2025-01-16 N-Gene Research Laboratories, Inc. Increasing telomere length and/or suppressing telomere shortening

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU9502843D0 (en) 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component

Also Published As

Publication number Publication date
AU5499701A (en) 2001-10-30
KR20030011309A (ko) 2003-02-07
ES2267758T3 (es) 2007-03-16
HUP0001583D0 (en) 2000-06-28
WO2001079174A8 (en) 2002-12-27
WO2001079174A1 (en) 2001-10-25
RS51003B (sr) 2010-10-31
ZA200208460B (en) 2003-10-20
HK1055741A1 (en) 2004-01-21
US7126002B2 (en) 2006-10-24
CZ20023445A3 (cs) 2003-03-12
PL359826A1 (en) 2004-09-06
BG107199A (bg) 2003-07-31
IL152337A0 (en) 2003-05-29
RU2281282C2 (ru) 2006-08-10
SK15082002A3 (sk) 2003-05-02
NO20025015L (no) 2002-12-16
JP2004501080A (ja) 2004-01-15
RU2002130710A (ru) 2004-03-20
SK287606B6 (sk) 2011-03-04
DK1274685T3 (da) 2006-11-06
BRPI0110184B8 (pt) 2021-05-25
EP1274685B1 (de) 2006-07-12
EE05085B1 (et) 2008-10-15
CZ301576B6 (cs) 2010-04-21
HUP0001583A2 (hu) 2002-11-28
MXPA02010320A (es) 2004-09-06
NZ522017A (en) 2004-06-25
AU2001254997B2 (en) 2006-11-23
CN1434800A (zh) 2003-08-06
PT1274685E (pt) 2006-09-29
DE60121431D1 (de) 2006-08-24
UA75353C2 (en) 2006-04-17
EE200200591A (et) 2004-04-15
CA2406266A1 (en) 2001-10-25
BRPI0110184B1 (pt) 2015-12-29
EP1274685A1 (de) 2003-01-15
BR0110184A (pt) 2003-06-17
US20040006232A1 (en) 2004-01-08
BG65889B1 (bg) 2010-04-30
IL152337A (en) 2007-10-31
JP5066638B2 (ja) 2012-11-07
HRP20020825A2 (en) 2004-12-31
CN1216868C (zh) 2005-08-31
NO323535B1 (no) 2007-06-04
DE60121431T2 (de) 2007-01-18
CA2406266C (en) 2010-07-20
KR100742482B1 (ko) 2007-07-25
NO20025015D0 (no) 2002-10-18
YU78302A (sh) 2005-09-19
SI1274685T1 (sl) 2006-10-31
CY1107473T1 (el) 2012-12-19

Similar Documents

Publication Publication Date Title
DE60121431D1 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
SE9904505D0 (sv) Novel compounds
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
BRPI0408681A (pt) compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos
ATE308327T1 (de) Verwendung von 2-hydroxy-5-phenylazobenzoesäure- derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
PL367447A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
FR2850576B1 (fr) Composition comprenant un melange de principes actifs, et procede de preparation
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
UA41978C2 (uk) N-метил-n-[(1s)-1-феніл-2-((3s)-3-гідроксипіролідин-1-іл)етил]-2,2- дифенілацетамід гідрохлорид, спосіб його отримання та фармацевтична композиція
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
YU31995A (sh) Benzotiofeni glikopiranozida, postupak za njihovo dobijanje i njihova farmaceutska formulacija
DE69828522D1 (de) Antithrombotische mittel
UA81610C2 (ru) Изохинолиновые соединения, способ их получения и фармацевтическая композиция, которая их содержит
NO20034985D0 (no) Nye 5-tio-SS-D-xylopyranosid-derivater, fremgangsmåte for fremstilling derav, farmasöytiske blandinger inneholdende dem og den terapeutiskeanvendelse derav
DE69905490D1 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
IT1273455B (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
SE0002354D0 (sv) New formulation
WO2002034203A3 (en) Novel derivatives of phenyl 4-aminosalicylate and method of making the same
ATE402178T1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza- benzoäcüfluoren-6-carbonsäurederivate als nmda- antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1274685

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee